Novel Immunotherapies for Hematological Malignancies

E-ISSN： 1874-4702|9|3|264-271

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.9, Iss.3, 2016-09, pp. : 264-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib: Proteasome Inhibition as a Novel Mechanism of Cancer Therapy-Implications for Hematological Malignancies

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 82-86

Bentham Science Publishers

Access to resources Recommend Favorite

ENMD-2076 for hematological malignancies

By How Jonathan Yee Karen

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 717-732

Informa Healthcare

Access to resources Recommend Favorite

Novel biological immunotherapies for psoriasis

By Kanitakis Jean Butnaru Agripina Cristina Claudy Alain

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1111-1121

Informa Healthcare

Access to resources Recommend Favorite

The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 537-548

Bentham Science Publishers

Access to resources Recommend Favorite

Corticoisteroid-Induced Apoptosis in Hematological Malignancies

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 1, 2009-03 ,pp. : 38-46

Bentham Science Publishers

Access to resources Recommend Favorite